A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether acetylsalicylic acidis effective on the
recurrence and survival of colon cancer patients.
Phase:
Phase 3
Details
Lead Sponsor:
Leiden University Leiden University Medical Center
Collaborators:
Anticancer Fund, Belgium Dutch Colorectal Cancer Group Fonds NutsOhra Innovatiefonds Zorgverzekeraars Stichting Geriatrische Oncologie Nederland (GeriOnNe) Stichting voor Patienten met Kanker aan het Spijsverteringskanaal (SPKS)